Cadamuro, M., Sarcognato, S., Camerotto, R., Girardi, N., Lasagni, A., Zanus, G., et al. (2023). Intrahepatic cholangiocarcinoma developing in patients with metabolic syndrome is characterized by Osteopontin overexpression in the tumor stroma. In Abstract Book of EASL Congress 2023 21-24 June 2023 • Vienna, Austria (pp.564-565). Elsevier [10.1016/S0168-8278(23)01358-2].

Intrahepatic cholangiocarcinoma developing in patients with metabolic syndrome is characterized by Osteopontin overexpression in the tumor stroma

Cadamuro, M;Strazzabosco, M;
2023

abstract + poster
cholangiocarcinoma, osteopontin, extracellular matrix, metabolic syndrome
English
EASL Congress 2023 - 21-24 June 2023
2023
Abstract Book of EASL Congress 2023 21-24 June 2023 • Vienna, Austria
2023
78
S1 (June 2023)
564
565
SAT-283
https://www.sciencedirect.com/journal/journal-of-hepatology/vol/78/suppl/S1?page=1
none
Cadamuro, M., Sarcognato, S., Camerotto, R., Girardi, N., Lasagni, A., Zanus, G., et al. (2023). Intrahepatic cholangiocarcinoma developing in patients with metabolic syndrome is characterized by Osteopontin overexpression in the tumor stroma. In Abstract Book of EASL Congress 2023 21-24 June 2023 • Vienna, Austria (pp.564-565). Elsevier [10.1016/S0168-8278(23)01358-2].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/466802
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact